Sponsor pipeline

George Washington University clinical trial pipeline

Get alerts when George Washington University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

6 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 4 with minor changes only.

Show 4 trials with minor changes only
  1. Minor

    Basket Clinical Study to Assess Glycerol Tributyrate · Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)

    Primary completion pushed from Mar 2028 to Sep 2028

    Also in this update: Study completion pushed from Mar 2028 to Nov 2028

    George Washington UniversityPhase 1/2 NCT06792500 Registry history of NCT06792500 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-13 NCT07871448 Flu COVID Vaccine Views Not Yet Recruiting

Active trials by phase

Phase 1
4
Phase 1/2
1
Phase 2
5
Phase 3
5
Phase 4
2
Not charted: 27 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 16

Get alerts when George Washington University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free